Anemia, Hemolytic, Warm Antibody
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Anemia, Hemolytic, Warm Antibody is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Warm Reacting Antibody Disease
- Idiopathic Warm Antibody Hemolytic Anemia
- Primary Warm Antibody Hemolytic Anemia
- Warm Antibody Autoimmune Hemolytic Anemia
- Warm Autoimmune Hemolytic Anemia secondary to IgM Autoantibodies
- Warm-reactive AIHA secondary to IgM
Warm antibody hemolytic anemia is an autoimmune disorder characterized by the premature destruction of healthy red blood cells by autoantibodies. Autoimmune diseases occur when the body's natural defenses against foreign organisms (e.g., lymphocytes, antibodies) destroy healthy tissue for unknown reasons. Normally, red blood cells have a life span of approximately 120 days before they are removed by the spleen. The medical term for low levels of circulating red blood cells is anemia. Anemia may cause fatigue, a pale skin color (pallor), yellowing of the skin and whites of the eyes (jaundice) and the passage of blood in the urine (hemoglobinuria), which gives the urine a dark brown color. Warm antibody hemolytic anemia is classified as an autoimmune hemolytic anemia (AIHA), an uncommon group of disorders in which the immune system mistakenly attacks healthy red blood cells.
NIH/National Heart, Lung and Blood Institute
31 Center Drive MSC 2480
Building 31A Rm 4A16
Bethesda, MD 20892-2480
MUMS National Parent-to-Parent Network
150 Custer Court
Green Bay, WI 54301-1243
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
Anemia Institute for Research and Education
151 Bloor Street West
Toronto, Ontario, M5S 1S4
Cold Agglutinin Disease E-Support
c/o Betty Usdan
146 Greens Rd.
Hollywood, FL 33021
Tel: (919) 552-9057
For a Complete Report
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc. ® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html